NCT05407480Recruiting
Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 2 Jun 2022
- Start date
- 15 Nov 2022
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- French Africa Pediatric Oncology Group
- Diseases
- Childhood cancers
- NCT number
- NCT05407480
What you commit to
- Study type: Observational
- Planned participants: 250
- From 15 Nov 2022 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Age
- Over 18 years of age at diagnosis
Who the study is looking for
- under 18 years of age at diagnosis
- suffering from "classical" Hodgkin's disease according to the WHO classification.
- with no history of hematological malignancies or constitutional or acquired immune deficiencies
Age in the registry: 0 months to 18 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brenda Mallon Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.